☆ 4.7 Article

Natural polysaccharide-based smart CXCR4-targeted nano-system for magnified liver fibrosis therapy

CHINESE CHEMICAL LETTERS (2024)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Liver fibrosis therapy based on biomimetic nanoparticles which deplete activated hepatic stellate cells

Shenglong Xia et al.

Summary: Liver fibrosis is a common liver disease with significant morbidity and mortality. However, there is still a lack of effective therapy for liver fibrosis. In this study, biomimetic all-trans retinoic acid (ATRA) loaded PLGA nanoparticles (NPs) were developed to deplete activated hepatic stellate cells (aHSCs) by inducing apoptosis and quiescence. The NPs were coated with HSC membranes expressing tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), and ATRA was encapsulated in the core. The biomimetic TM-ATRA/NPs showed the ability to induce both apoptosis and quiescence in aHSCs, leading to improved fibrosis amelioration in mouse models.

JOURNAL OF CONTROLLED RELEASE (2023)

Add to Collection

Article Gastroenterology & Hepatology

Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling

Chen-Ting Hung et al.

Summary: The study identified TXNDC5 as a critical mediator of liver fibrosis, showing that its upregulation is associated with the activation of HSCs and the production of excessive extracellular matrix. Targeting TXNDC5 could potentially be a novel therapeutic strategy to ameliorate liver fibrosis.

GUT (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Ultrasound-Responsive Aqueous Two-Phase Microcapsules for On-Demand Drug Release

Rachel D. Field et al.

Summary: In this study, we have developed a microfluidic system that can trigger drug release using focused ultrasound. The microcapsules made of hydrogels can release drugs as desired and have shown biocompatibility and wireless triggerability.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Add to Collection

Article Engineering, Biomedical

Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis

Pengkai Wu et al.

Summary: A versatile nanocomplex was developed that improved liver fibrosis therapy by overcoming biological barriers and co-regulating Kupffer cells, extracellular matrix, and hepatic stellate cells.

BIOMATERIALS (2022)

Add to Collection

Article Dentistry, Oral Surgery & Medicine

The combination of experimental periodontitis and oral microbiota from periodontitis patients aggravates liver fibrosis in mice

Lan Bai et al.

Summary: This study found that periodontitis worsens carbon tetrachloride-induced hepatic dysfunction and fibrosis in mice, likely through increased inflammation and alteration of microbiota in the liver.

JOURNAL OF CLINICAL PERIODONTOLOGY (2022)

Add to Collection

Article Endocrinology & Metabolism

S100a16 deficiency prevents hepatic stellate cells activation and liver fibrosis via inhibiting CXCR4 expression

Wen-Song Zhang et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Reactive Oxygen Species-Responsive Polypeptide Drug Delivery System Targeted Activated Hepatic Stellate Cells to Ameliorate Liver Fibrosis

Yumei Hao et al.

Summary: Hepatic fibrosis is a chronic liver disease that lacks effective pharmacotherapeutic treatments. Researchers have designed targeted and reactive oxygen species (ROS)-responsive micelles for the specific delivery of resveratrol (RES), a traditional Chinese medicine, to activated hepatic stellate cells (aHSCs) for the treatment of liver fibrosis. In vitro and in vivo experiments demonstrate that these micelles enhance the targeted delivery of RES to aHSCs, reduce collagen accumulation, and protect hepatocytes from damage.

ACS NANO (2022)

Add to Collection

Review Chemistry, Multidisciplinary

Polysaccharide-based supramolecular drug delivery systems mediated via host-guest interactions of cucurbiturils

Yiyun Gao et al.

Summary: Natural polysaccharides and their derivatives have great potential in drug delivery, with reversible crosslinking by Cucurbit[n]uril showing stimulus responsiveness for constructing stimuli-responsive drug release systems. The host-guest interactions of CB[6] and CB[8] in polysaccharide-based supramolecular drug delivery systems allow for easy tuning of rheological properties and drug release profiles.

CHINESE CHEMICAL LETTERS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

ROS-responsive cyclodextrin nanoplatform for combined photodynamic therapy and chemotherapy of cancer

Die Jia et al.

Summary: Cyclodextrin is widely used for constructing CD-based nanoplatforms due to its special spatial structure and good biological safety. The study designed a highly sensitive ROS-responsive polymer PCP encapsulating doxorubicin (DOX) and purpurin 18 (P18) for synergistic photodynamic and chemotherapy effects. The micelles showed enhanced anti-cancer activity through the release of drugs triggered by ROS in the tumor microenvironment.

CHINESE CHEMICAL LETTERS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery

Nianan Luo et al.

Summary: The study demonstrated the efficient delivery of CRISPR/dCas9-VP64 system into HSCs via exosomes derived from AML12 cells, leading to induction of HSCs into hepatocyte-like phenotype, thus providing a potential gene therapy strategy for hepatic fibrosis treatment.

DRUG DELIVERY (2021)

Add to Collection

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Synthesis of polypeptide bearing 1,4-dithiane pendants for ROS-responsive drug release

Tianhui Zhang et al.

CHINESE CHEMICAL LETTERS (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

Maurizio Parola et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Serum response factor (SRF) promotes ROS generation and hepatic stellate cell activation by epigenetically stimulating NCF1/2 transcription

Ming Kong et al.

REDOX BIOLOGY (2019)

Add to Collection

Article Toxicology

Molecular hepatoprotective effects of lipoic acid against carbon tetrachloride-induced liver fibrosis in rats: Hepatoprotection at molecular level

K. M. Sadek et al.

HUMAN & EXPERIMENTAL TOXICOLOGY (2018)

Add to Collection

Article Endocrinology & Metabolism

Relationship Between Metabolic Syndrome, Alanine Aminotransferase Levels, and Liver Disease Severity in a Multiethnic North American Cohort With Chronic Hepatitis B

Mandana Khalili et al.

DIABETES CARE (2018)

Add to Collection

Article Materials Science, Biomaterials

Macrophage-targeting and reactive oxygen species (ROS)-responsive nanopolyplexes mediate anti-inflammatory siRNA delivery against acute liver failure (ALF)

Wenxin Zhang et al.

BIOMATERIALS SCIENCE (2018)

Add to Collection

Article Cell Biology

Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells

Zili Zhang et al.

AUTOPHAGY (2018)

Add to Collection

Review Gastroenterology & Hepatology

Mechanisms of hepatic stellate cell activation

Takuma Tsuchida et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell

Zili Zhang et al.

REDOX BIOLOGY (2017)

Add to Collection

Article Engineering, Biomedical

Reactive oxygen species-responsive polymeric nanoparticles for alleviating sepsis-induced acute liver injury in mice

Gan Chen et al.

BIOMATERIALS (2017)

Add to Collection

Review Pharmacology & Pharmacy

Hepatic stellate cells as key target in liver fibrosis

Takaaki Higashi et al.

ADVANCED DRUG DELIVERY REVIEWS (2017)

Add to Collection

Article Medicine, Research & Experimental

Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver Fibrosis

Chun-Hung Liu et al.

MOLECULAR PHARMACEUTICS (2016)

Add to Collection

Article Engineering, Biomedical

CXCR4-targeted lipid-coated PLGA nanoparticles deliver sorafenib and overcome acquired drug resistance in liver cancer

Dong-Yu Gao et al.

BIOMATERIALS (2015)

Add to Collection

Article Gastroenterology & Hepatology

S100A4 promotes liver fibrosis via activation of hepatic stellate cells

Lin Chen et al.

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Differential Effects of Sorafenib on Liver Versus Tumor Fibrosis Mediated by Stromal-Derived Factor 1 Alpha/C-X-C Receptor Type 4 Axis and Myeloid Differentiation Antigen-Positive Myeloid Cell Infiltration in Mice

Yunching Chen et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Hepatic Stellate Cells Express Functional CXCR4: Role in Stromal Cell-Derived Factor-1α-Mediated Stellate Cell Activation

Feng Hong et al.

HEPATOLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.